OCA

Octagon Capital Advisors Portfolio holdings

AUM $456M
1-Year Est. Return 48.55%
This Quarter Est. Return
1 Year Est. Return
+48.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$508M
AUM Growth
-$79.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$47.6M
2
+$20.9M
3
+$13.8M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$11.6M
5
VSTM icon
Verastem
VSTM
+$10.4M

Top Sells

1
+$22.9M
2
+$22.5M
3
+$20M
4
DYN icon
Dyne Therapeutics
DYN
+$15.7M
5
BBIO icon
BridgeBio Pharma
BBIO
+$12.1M

Sector Composition

1 Healthcare 90.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVB.WS icon
1
Nuvation Bio Inc Warrants
NUVB.WS
$56.1M
$48.1M 9.31%
27,330,800
+27,018,464
APLS icon
2
Apellis Pharmaceuticals
APLS
$3.08B
$45.8M 8.86%
2,094,000
-912,980
DNTH icon
3
Dianthus Therapeutics
DNTH
$1.42B
$42.5M 8.22%
2,341,667
+231,500
AVBP icon
4
ArriVent BioPharma
AVBP
$806M
$38.1M 7.37%
2,059,387
TRVI icon
5
Trevi Therapeutics
TRVI
$1.27B
$20.9M 4.04%
+3,322,000
CNTA
6
Centessa Pharmaceuticals
CNTA
$3.09B
$20.5M 3.97%
1,425,000
-568,052
GOSS icon
7
Gossamer Bio
GOSS
$524M
$20.2M 3.91%
18,350,000
OCUL icon
8
Ocular Therapeutix
OCUL
$2.5B
$17.8M 3.44%
2,425,000
MNMD icon
9
MindMed
MNMD
$912M
$17.7M 3.42%
3,018,000
COGT icon
10
Cogent Biosciences
COGT
$2.28B
$16.6M 3.2%
2,763,000
KALV icon
11
KalVista Pharmaceuticals
KALV
$560M
$15.8M 3.06%
1,370,000
TSHA icon
12
Taysha Gene Therapies
TSHA
$1.25B
$14.9M 2.88%
10,700,000
+250,000
NUVB icon
13
Nuvation Bio
NUVB
$1.22B
$13.9M 2.69%
7,900,000
-1,302,907
VRNA
14
DELISTED
Verona Pharma
VRNA
$13.8M 2.67%
217,264
-354,000
TRML icon
15
Tourmaline Bio
TRML
$1.23B
$13.8M 2.66%
+905,000
MRUS icon
16
Merus
MRUS
$7.18B
$13M 2.51%
308,000
PHVS icon
17
Pharvaris
PHVS
$1.4B
$12.1M 2.34%
769,815
-8,185
MLTX icon
18
MoonLake Immunotherapeutics
MLTX
$570M
$11.6M 2.24%
+296,000
SNDX icon
19
Syndax Pharmaceuticals
SNDX
$1.31B
$11.1M 2.15%
904,000
ATYR
20
aTyr Pharma
ATYR
$99M
$10.7M 2.08%
3,552,000
+2,652,000
SRRK icon
21
Scholar Rock
SRRK
$2.77B
$10.6M 2.05%
329,000
-159,000
VSTM icon
22
Verastem
VSTM
$566M
$10.4M 2.01%
+1,720,000
RGLS
23
DELISTED
Regulus Therapeutics
RGLS
$8.11M 1.57%
4,637,076
-211,726
SPRY icon
24
ARS Pharmaceuticals
SPRY
$983M
$7.86M 1.52%
+625,000
ABVX
25
Abivax
ABVX
$7.16B
$7.69M 1.49%
+1,230,000
1
2